Plain-English translation of NCT05999084 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →This trial is tracking how well lecanemab and similar medications work for people with mild cognitive impairment or early Alzheimer's disease in real-world care settings. Researchers will compare how people who receive this medication fare over time compared to similar patients who were treated before the medication became available. The goal is to understand whether this new treatment truly helps patients and caregivers in everyday practice.
While this medication showed promise in large research studies, doctors and insurance companies want to understand how well it actually works for typical patients in regular clinics and whether any safety concerns arise when used more widely. This study will help answer those real-world questions.
If you join, you'll receive the medication as part of your regular Alzheimer's care at one of the participating memory clinics in Georgia. You'll have regular follow-up visits where doctors will test your thinking and memory using standard assessments and may order brain scans to monitor safety. Your caregiver will also be asked to attend visits and share observations about how you're doing day-to-day.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
United States